News
Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration.
The upscale establishment features $10 cocktails made with Ohio-distilled spirits and a rotating bar menu that includes local ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback